pharma news today glp-1 obesity drugs today Giants Bet on Next-Generation Treatments to Sustain Growth Pfizer moves forward with weight-loss

Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients with Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial

Not enrolled or qualified for any federal, state, or government program like Medicaid, Low Income Subsidy, or Veterans Affairs (VA) Benefits

The GLP-1 Gold Rush GLP-1 receptor agonists have quickly become some of the most profitable drugs in pharmaceutical history

But its getting more attention because some people on GLP-1 drugs developed the condition

Effects of GLP-1 and Other Gut Hormone Receptors on the Gastrointestinal Tract and Implications in Clinical Practice